Helicobacter spp. | Campylobacter spp. | |
---|---|---|
N | 16 | 14 |
Age (years), mean ± SD | 61 ± 18 | 49 ± 21 |
Sex (male) | 10 | 8 |
Hospital-acquired infection* | 7 (43.8%) | 1 (7.1%) |
Animal contact | 3 (18.8%) | 1 (7.1%) |
Underlying diseases | 16 (100%) | 10 (71.4%) |
Solid organ cancer | 8 | 4 |
Hematological malignancy | 4 | 1 |
Liver cirrhosis | 4 | 2 |
Collagen vascular disease | 2 | 1 |
Others | 2 | 5 |
Side effects of immunosuppressants (including chemotherapy for cancer)* | 8 (50%) | 1 (7.1%) |
Clinical manifestations | ||
Fever (> 37.5 °C) | 11 | 13 |
Diarrhea† | 0 | 7 |
Skin lesion* | 8 | 1 |
Arthralgia | 0 | 3 |
Headache | 2 | 3 |
Others | 2 | 5 |
No apparent symptom | 5 | 1 |
*Body temperature (°C), mean ± SD | 38.1 ± 1.0 | 38.8 ± 0.9 |
Treatment | ||
No antibiotics | 1 | 1 |
Penicillin | 11 | 2 |
Cephalosporin | 9 | 7 |
β-lactamase/β-lactam | 4 | 4 |
Carbapenem | 5 | 3 |
Macrolide | 2 | 2 |
Fluoroquinolone | 2 | 3 |
Doxycycline/minocycline | 12 | 2 |
Others | 0 | 1 |
Total duration of antibiotic treatment (days),mean ± SD† | 36 ± 26 | 10 ± 8 |
Persistent bacteremia (> 48 h) | 2 | 0 |
Recurrent case | 3 | 0 |